FDA approves admission to Antineoplaston Trial for PNET-Brain Tumor-DVD's

[Guest guest]

November 30, 2010

Dear Burzynski Movie subscribers,

We hope everyone had a pleasant Thanksgiving. We have some holiday news to

annouce: (1) Some recent headway has been made in the FDA's mandate to

force all patients to fail chemotherapy and radiation before being allowed to

be treated in Antineoplastons clinical trials, and (2) we have a holiday

special on DVDs.

Holiday Special:

The holiday season is upon us, and while we all love buying fancy gadgets

that have flashing lights and make funny noises for our friends and family

for the holidays, we are offering DVD orders of " Two Packs " and " Ten Packs "

at a reduced rate from now until December 20, 2010.

(https://www.burzynskimovie.com/index.php?page=shop.product_details & flypage=flyp\

age_images.tpl & prod

uct_id=8 & category_id=1 & option=com_virtuemart & Itemid=69)

_

" Two Packs " are reduced to $30.00_

(https://www.burzynskimovie.com/index.php?page=shop.product_details & flypage=flyp\

age_images.tpl & product_id=8 & category_

id=1 & option=com_virtuemart & Itemid=69) (from $35.00) and _ " Ten Packs " are

reduced to $120.00_

(https://www.burzynskimovie.com/index.php?page=shop.product_details & flypage=flyp\

age_images.tpl & product_id=18 & category_id=1 & option=co

m_virtuemart & Itemid=69) (from $150.00). They will return to regular price

after December 20, 2010.

We are launching a new public relations campaign for this project in 2011,

and all DVD sales will help fund this next new push. We are hiring some

big guns to get behind this project, and they aren't cheap.

Recent positive headway with the Food and Drug Administration:

As we've said all along, the first step in moving forward and getting

Antineoplastons approved for public use is getting the public at large aware of

this medicine and it's background. Without massive public support, we will

see no change. This is beginning to happen.

Just recently, a family with a 22 month old girl in Washington State with

a PNET brain tumor (Primitive Neureoectodermal Tumor) contacted

Burzynski's clinic for treatment. While data shows that " traditional treatment "

has a

track record of treating this type of cancer, " however, difficulties with

standard treatment can be encountered in very young children, in adults at

high risk of complication from standard treatment (meaning chemotherapy

doesn't really cut through the brain blood barrier, and is highly toxic - and

radiation is, well... radiation) and patients with recurrent tumors " .

This little 22 month old girl falls into two of those categories, being

both an " young child " and also having " recurrent tumors " .

Here is essentially the course of events regarding this case:

1. 22 month old diagnosed with a brain tumor, she had surgery to remove

the tumor. Post surgery, a biopsy showed it to be a PNET brain tumor.

2. The family was given the choice of " standard treatment " which offered a

low percentage of survival, plus the massive side effects chemotherapy and

radiation would have on this child.

3. The family found the Burzynski clinic, and were notified that they

would not be able to treat this 22 month old since the FDA requires that she

needed to fail chemotherapy and radiation; and also because of her young age.

4. The family talked to many people, including Merola (me) and wanted

to try to get a " Special Exception " for this child. Everyone informed them

that the only way to get the FDA to change their mind is if a Congressman

or Senator intervened, but even then there was no guarantee.

5. A second post-surgical scan showed the tumor was not only growing back,

but there were now multiple tumors in her brain.

6. This family contacted Senator Cantwell's office, and explained

the situation.

7. Incredibly, because of this single Senator's inquiry, the FDA is now

allowing this child to be treated in an Antineoplaston clinical trial without

being forced to fail chemotherapy and radiation, and, the age requirement!

This is exactly what we have been talking about! Historically, the FDA has

been known to back down when a spotlight is shined on them. This is a

prime example of what public awareness and public pressure can do—as there is

no scientific basis for the FDA's mandate, only red tape. That red tape can

easily be cut when given a sharp enough pair of scissors—and armed with the

science. Senator Cantwell, in this case, pulled the scissors out and

managed to cut this one. This is landmark, and sets a precedent in how we can

possibly win this. As we've always said, it takes " the people " to push and

make the change.

Allowing this child into Burzynski's clinical trial is only half the

battle. In a group of Phase II clinical trials using only Antineoplastons, with

13 children ranging from one to eleven years old with PNET tumors: Six of

those patients (46%) survived more than 5 years after treatment. Five of

the six patients had not undergone any previous chemotherapy or radiation

prior to being treated with Antineoplastons - they came in clean. This

22-month-old child from Washington State has the opportunity to enter these

trials

clean as well. _Click here for to read the published study yourself. _

(http://ict.sagepub.com/content/4/2/168.abstract)

In contrast, a chemotherapy drug produced by GlaxoKline called

Topotecan (also a gene-targeted drug), is undergoing Phase II trials for this

type of tumor in children as well. Twenty-six children were treated, two

objective responses were noted (7.6%), and these two patients managed to live

beyond five years. However, this does not indicate the damage, if any, this

chemotherapeutic drug caused these patients.

Therefore, in virtually identical Phase II gene-targeted clinical trials

treating PNET in children: topotecan chemotherapy resulted in a 7.6% 5-year

survival; while Antineoplastons resulted a 46% 5-year survival. _Click here

to read this study._ (http://www.ncbi.nlm.nih.gov/pubmed/21108437) It's

important to note that while Antineoplastons are free of harmful side

effects, topotecan's side effects generally include: hair loss, vomiting, and

diarrhea—if you are lucky. If you are one that has a more severe reaction to

this drug, the side effects can include: difficulty breathing; swelling of

the face, lips and tongue; severe cough; painful urination, unexplained

bruising, and stomach cramps. _Click here more on this drug._

(http://www.drugs.com/sfx/topotecan-side-effects.html)

The science is clear.

The upcoming public relations campaign will focus directly on all of these

issues. Keep spreading the word and sharing the DVD. We will soon have

available for everyone a " call to action " for you to utilize to notify your

Congressman and Senator of this issue and more.

In solidarity,

Merola

Director, _Burzynski, The Movie_ (https://www.burzynskimovie.com/)

Please note: Burzynski The Movie, it's website, and this newsletter is an

independent entity, not directly affiliated with Dr. Burzynski, The

Burzynski Clinic, or The Burzynski Research Institute. We are merely a group of

advocates that want nothing more than to see Antineoplastons approved for

public use.

Your Subscription:

_Change your subscription_

(http://www.burzynskimovie.com/index.php?option=com_acajoom & Itemid=999 & act=chang\

e & subscriber=957 & cle=dbacde5154a121851b7cf45c

6d0253c5 & listid=1)

_Unsubscribe_

(http://www.burzynskimovie.com/index.php?option=com_acajoom & Itemid=999 & act=unsub\

scribe & subscriber=957 & cle=dbacde5154a121851b7cf45c6d0253c5

& listid=1) _

Powered by Joobi_ (http://www.ijoobi.com/)